Investigators reported an 88% early treatment success rate in 52 men who underwent MRI-guided transurethral ultrasound ablation for localized prostate cancer.
Men who take 5-alpha-reductase inhibitors while on active surveillance for prostate cancer are less likely to experience cancer progression, according to a new study
Use of glycolysis-enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin
It is important for urologists and primary care physicians to be aware of the potential link between BPH medications and heart failure risk, according to investigators.
At 24 months after treatment for refractory BPH symptoms, patients who underwent transurethral resection of the prostate had more pronounced improvements in most functional outcomes compared with those treated with prostatic artery embolization, a study found.
In a small study, add-on vibegron appeared well-tolerated and clinically effective among men with persistent OAB.
A meta-analysis evaluated the efficacy and safety of imidafenacin for overactive bladder induced by benign prostatic hyperplasia.
Thulium laser transurethral vaporesection of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia resulted in comparable improvements in International Prostate Symptom Score over 12 months.
The new guidance aims to support urologists and other clinicians in providing evidence-based care to their patients.
Greater daily temperature differences, the average number of visits to emergency departments for lower urinary tract symptoms due to benign prostatic hyperplasia increase, according to a large study of Korean men.